Inhibitory effects of anti-inflammatory drugs on type II collagen induced arthritis in rats.
K Yamaki,H Nakagawa,S Tsurufuji +2 more
Reads0
Chats0
TLDR
It is indicated that non-steroidal anti-inflammatory drugs having inhibitory action on cyclo-oxygenase are useful antiarthritic drugs without causing the rebound phenomenon, an untoward side effect after withdrawal of steroidal anti- inflammatory drugs.Abstract:
The effects of steroidal and non-steroidal anti-inflammatory drugs on the established lesion of type II collagen induced arthritis in rats were evaluated by measuring the hind paw oedema and anti-type II collagen antibody titre. Dexamethasone, a steroidal anti-inflammatory drug, reduced the anti-type II collagen antibody titre and markedly suppressed the established lesion of type II collagen induced arthritis in rats. A rebound of the arthritis, i.e., a rapid recovery of the hind paw swelling took place after withdrawal of the treatment with steroidal anti-inflammatory drugs, including dexamethasone, prednisolone, and hydrocortisone. On the other hand, indomethacin, benoxaprofen, piroxicam, and tiflamizole, which are cyclo-oxygenase inhibitors in prostaglandin synthesis, had no effect on anti-type II collagen antibody titre, but suppressed the established lesion of the arthritis without causing an apparent rebound of the arthritis after withdrawal of the drug treatment. These results suggest that the level of anti-type II collagen antibodies has no relation to the intensity of hind paw swelling in the established lesion of the arthritis, though the antibodies contribute to the incidence of the arthritis. It also indicates that non-steroidal anti-inflammatory drugs having inhibitory action on cyclo-oxygenase are useful antiarthritic drugs without causing the rebound phenomenon, an untoward side effect after withdrawal of steroidal anti-inflammatory drugs.read more
Citations
More filters
Journal ArticleDOI
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
TL;DR: Examination of the efficacy of various compounds in these animal models revealed that a compound's therapeutic efficacy, rather than prophylactic efficacy, in AIA and CIA models was more predictive of clinical efficacy in human RA than data from either model alone.
Journal ArticleDOI
Resolution‐associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
TL;DR: It is proposed that heat shock protein 10, αB‐crystallin, αBC, HSP27 and binding immunoglobulin protein (BiP) should be considered founding members of the RAMP family and a greater understanding of RAMP biology may herald the development of novel immunotherapies.
Journal ArticleDOI
Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.
Samra Sardar,Åsa Andersson +1 more
TL;DR: A number of existing rodent models for Rheumatoid Arthritis are reviewed in the context of how these models have been utilized for developing established therapy in Rhe autoimmune diseases and, furthermore, the present use of animal models for studies of novel drug candidates.
Journal ArticleDOI
Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs.
TL;DR: Because of the shorter latent period required for the development of arthritis in theIL-1 treated animals, the IL-1 accelerated CIA model in both mice and rats may be useful for screening anti-inflammatory or anti-arthritic compounds.
Journal ArticleDOI
Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.
TL;DR: It is suggested that DA rats are more susceptible to CIA than Lewis rats and that CIA in DA rats as well as in Lewis rats is serviceable as an experimental animal model of rheumatoid arthritis.
References
More filters
Journal ArticleDOI
Autoimmunity to type II collagen an experimental model of arthritis.
TL;DR: Since homologous type II collagen emulsified in oil without bacterial preparations regularly causes the disease, this new animal model of arthritis represents a unique example of experimentally-inducible autoimmunity to a tissue component.
Journal ArticleDOI
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells
TL;DR: In this article, the authors studied cells dispersed with proteolytic enzymes from rheumatoid arthritic synovectomy specimens to determine the cell type(s) responsible for joint destruction, and found that 10-50% of these cells adhered to culture dishes within 24 hours and were of two main types: small, round cells and larger, stellate cells.
Journal ArticleDOI
Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis.
TL;DR: It is concluded that the bone resorption-stimulating activity produced by rheumatoid synovia in culture is PGE2, itself a potent osteolytic factor.
Journal ArticleDOI
Collagen arthritis as a relevant model for rheumatoid arthritis. evidence pro and con
Journal ArticleDOI
The pharmacology of benoxaprofen (2‐[4‐chlorophenyl]‐α‐methyl‐5‐benzoxazole acetic acid), LRCL 3794, a new compound with anti‐inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis
TL;DR: Benoxaprofen has analgesic activity in tests where pain is accompanied by inflammation but not in other experimental models of pain, and its low ulcerogenic potential in animal models may be related to its relative inability to inhibit PG synthetase.
Related Papers (5)
Assessment of drugs for activity in established type II collagen arthritis.
Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
K Phadke,J Carroll,S Nanda +2 more